Brian McNamara, Haleon CEO
Haleon ups full-year guidance after rocky spinoff from GSK
After getting off to a rather rocky start in July, GSK’s consumer health spinoff Haleon is upping its full-year sales guidance on the heels of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
